Correlation of Biochemical Indexes and Retinal Hemodynamic in Patients With Different Degrees of Diabetic Retinopathy
NCT ID: NCT05902650
Last Updated: 2023-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2021-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multimodal Biomarkers in Prediction of Diabetic Retinopathy
NCT07098832
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
NCT06821399
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa
NCT00784901
Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography
NCT06457295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
diabetic patients with no diabetic retinopathy
imaging
imaging
Group 2
diabetic patients with mild nonproliferative diabetic retinopathy
imaging
imaging
Group 3
diabetic patients with moderate and severe nonproliferative diabetic retinopathy
imaging
imaging
Group 4
diabetic patients with proliferative diabetic retinopathy
imaging
imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
imaging
imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of any intraocular surgery or treatment (including intravitreal injection, retinal photocoagulation etc.
* with severe refractive medium opacity that could affect fundus examination.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mingzhe Cao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mingzhe Cao
Attending ophthalmologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mingzhe Cao
Role: PRINCIPAL_INVESTIGATOR
The Seventh Affiliated Hospital of Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Seventh Affiliated Hospital, Sun Yat-sen University
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.